Your browser doesn't support javascript.
loading
Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.
Sahasrabudhe, Ruta; Lott, Paul; Bohorquez, Mabel; Toal, Ted; Estrada, Ana P; Suarez, John J; Brea-Fernández, Alejandro; Cameselle-Teijeiro, José; Pinto, Carla; Ramos, Irma; Mantilla, Alejandra; Prieto, Rodrigo; Corvalan, Alejandro; Norero, Enrique; Alvarez, Carolina; Tapia, Teresa; Carvallo, Pilar; Gonzalez, Luz M; Cock-Rada, Alicia; Solano, Angela; Neffa, Florencia; Della Valle, Adriana; Yau, Chris; Soares, Gabriela; Borowsky, Alexander; Hu, Nan; He, Li-Ji; Han, Xiao-You; Taylor, Philip R; Goldstein, Alisa M; Torres, Javier; Echeverry, Magdalena; Ruiz-Ponte, Clara; Teixeira, Manuel R; Carvajal-Carmona, Luis G.
Afiliação
  • Sahasrabudhe R; Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California.
  • Lott P; Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California.
  • Bohorquez M; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia.
  • Toal T; Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California.
  • Estrada AP; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia.
  • Suarez JJ; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia.
  • Brea-Fernández A; Fundación Pública Galega de Medicina Xenómica (FPGMX)-SERGAS, Grupo de Medicina Xenómica-USC, Instituto de Investigación Sanitaria de Santiago (IDIS), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 15706 Santiago de Compostela, Galicia, Spain.
  • Cameselle-Teijeiro J; Servicio de Anatomía Patológica, Hospital Clínico, Santiago de Compostela, Spain.
  • Pinto C; Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Ramos I; Unidad de Investigación en Enfermedades Infecciosas, UMAE Pediatría, Instituto Mexicano del Seguro Social; Mexico City, Mexico.
  • Mantilla A; Departamento de Patologia, La Unidad Medica Alta Especialidad Oncologia, Mexico City, Mexico.
  • Prieto R; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia.
  • Corvalan A; Advanced Center for Chronic Diseases (ACCDiS), Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Norero E; Advanced Center for Chronic Diseases (ACCDiS), Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Alvarez C; Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Tapia T; Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Carvallo P; Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Gonzalez LM; Universidad de Antioquia and Instituto de Cancerología Las Américas, Medellin, Colombia.
  • Cock-Rada A; Universidad de Antioquia and Instituto de Cancerología Las Américas, Medellin, Colombia.
  • Solano A; Instituto de Investigaciones Bioquímicas, Universidad de Buenos Aires/Consejo Nacional de Investigaciones Científicas y Técnicas y El Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina.
  • Neffa F; Laboratorio Genia, Montevideo, Uruguay.
  • Della Valle A; Laboratorio Genia, Montevideo, Uruguay.
  • Yau C; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Soares G; Centro de Genética Médica Dr Jacinto Magalhães, Centro Hospitalar do Porto, Porto, Portugal.
  • Borowsky A; Department of Pathology, School of Medicine, University of California, Davis, California.
  • Hu N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • He LJ; Yangcheng Cancer Hospital, Yangcheng, Shanxi, PR China.
  • Han XY; Shanxi Cancer Hospital, Taiyuan, Shanxi, PR China.
  • Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Goldstein AM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Torres J; Unidad de Investigación en Enfermedades Infecciosas, UMAE Pediatría, Instituto Mexicano del Seguro Social; Mexico City, Mexico.
  • Echeverry M; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia.
  • Ruiz-Ponte C; Fundación Pública Galega de Medicina Xenómica (FPGMX)-SERGAS, Grupo de Medicina Xenómica-USC, Instituto de Investigación Sanitaria de Santiago (IDIS), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 15706 Santiago de Compostela, Galicia, Spain.
  • Teixeira MR; Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal; Institute of Biomedical Sciences, University of Porto, Porto, Portugal.
  • Carvajal-Carmona LG; Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California; Fundación de Genómica y Genética Molecular, Colombia. Electronic address: lgcarvajal@ucdavis.edu.
Gastroenterology ; 152(5): 983-986.e6, 2017 04.
Article em En | MEDLINE | ID: mdl-28024868
ABSTRACT
Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Proteínas Nucleares / Proteína BRCA1 / Proteínas Supressoras de Tumor / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Proteínas Nucleares / Proteína BRCA1 / Proteínas Supressoras de Tumor / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Ano de publicação: 2017 Tipo de documento: Article